BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7631029)

  • 21. Parotid gland function after radiotherapy.
    Dirix P; Nuyts S
    Lancet Oncol; 2010 Jun; 11(6):515-6. PubMed ID: 20522382
    [No Abstract]   [Full Text] [Related]  

  • 22. Early-onset dropped head syndrome after radiotherapy for head and neck cancer: dose constraints for neck extensor muscles.
    Inaba K; Nakamura S; Okamoto H; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Takahashi K; Murakami N; Ito Y; Igaki H; Uno T; Itami J
    J Radiat Res; 2016 Mar; 57(2):169-73. PubMed ID: 26684338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous chemoradiation: accelerated hypofractionation.
    Alastuey I; Montagut J
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1201. PubMed ID: 7993448
    [No Abstract]   [Full Text] [Related]  

  • 24. Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose.
    Castelli J; Simon A; Rigaud B; Chajon E; Thariat J; Benezery K; Vauleon E; Jegoux F; Henry O; Lafond C; de Crevoisier R
    Acta Oncol; 2018 Sep; 57(9):1267-1270. PubMed ID: 29706107
    [No Abstract]   [Full Text] [Related]  

  • 25. Commentary: IMRT for head and neck cancer: many chapters left to write.
    Allen AM; Tishler RB
    Oncologist; 2007 May; 12(5):565-8. PubMed ID: 17522244
    [No Abstract]   [Full Text] [Related]  

  • 26. Comment on 'viability of the EUD and TCP concepts as reliable dose indicators'.
    Vaarkamp J; Zhu Y
    Phys Med Biol; 2000 Jul; 45(7):L11-6. PubMed ID: 10943940
    [No Abstract]   [Full Text] [Related]  

  • 27. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial.
    Overgaard J; Hansen HS; Specht L; Overgaard M; Grau C; Andersen E; Bentzen J; Bastholt L; Hansen O; Johansen J; Andersen L; Evensen JF
    Lancet; 2003 Sep; 362(9388):933-40. PubMed ID: 14511925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiation treatment breaks and ulcerative mucositis in head and neck cancer.
    Russo G; Haddad R; Posner M; Machtay M
    Oncologist; 2008 Aug; 13(8):886-98. PubMed ID: 18701763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Target coverage for head and neck cancers treated with IMRT: review of clinical experiences.
    Garden AS; Morrison WH; Rosenthal DI; Chao KS; Ang KK
    Semin Radiat Oncol; 2004 Apr; 14(2):103-9. PubMed ID: 15095256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotherapy employing three fractions in each day over a continuous period of 12 days.
    Saunders MI; Dische S
    Br J Radiol; 1986 May; 59(701):523-5. PubMed ID: 3708258
    [No Abstract]   [Full Text] [Related]  

  • 31. [Functional thyroid gland activity in malignant neoplasms of the head and neck after gamma teletherapy].
    Vorob'ev IuI; Zubovskiĭ GA; Popov NV; Korovkina EG
    Med Radiol (Mosk); 1978 Oct; 23(10):24-9. PubMed ID: 703542
    [No Abstract]   [Full Text] [Related]  

  • 32. [Injuries of the peripheral nervous system after radiotherapy].
    Kasperek S; Hamankiewicz E
    Neurol Neurochir Pol; 1989; 23(2):136-41. PubMed ID: 2693982
    [No Abstract]   [Full Text] [Related]  

  • 33. [Radiation-induced myelopathy].
    Kasperek S; Motta E
    Neurol Neurochir Pol; 1985; 19(2):144-8. PubMed ID: 3900781
    [No Abstract]   [Full Text] [Related]  

  • 34. Sagittal and coronal planes from MRI for treatment planning in tumors of brain, head and neck: MRI assisted simulation.
    Pötter R; Heil B; Schneider L; Lenzen H; al-Dandashi C; Schnepper E
    Radiother Oncol; 1992 Feb; 23(2):127-30. PubMed ID: 1546188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carcinoma of the tonsillar fossa. Significance of dose of irradiation and volume treated in the control of the primary tumor and metastatic neck nodes.
    Perez CA; Lee FA; Ackerman LV; Korba A; Purdy J; Powers WE
    Int J Radiat Oncol Biol Phys; 1976; 1(9-10):817-27. PubMed ID: 824256
    [No Abstract]   [Full Text] [Related]  

  • 36. Dose response of squamous cell carcinomas of the upper respiratory and digestive tracts.
    Thames HD; Peters LJ; Spanos W; Fletcher GF
    Br J Cancer Suppl; 1980 Apr; 4():35-8. PubMed ID: 6775658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes of failure of radiotherapy in head and neck cancer.
    Peters LJ; Fletcher GH
    Radiother Oncol; 1983 Aug; 1(1):53-63. PubMed ID: 6680213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of dose and volume on radiation-induced mucositis.
    Mantini G; Manfrida S; Cellini F; Giammarino D; Petrone A; Vitucci P; Cellini N
    Rays; 2005; 30(2):137-44. PubMed ID: 16294906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical examinations on the different fractionation rhythms for radiation therapy. Dynamic fractionation and behavior of heterogeneous tumor cell population (clinical and technical aspects)].
    Siracká E; Durkovský J; Jancina J
    Radiobiol Radiother (Berl); 1975; 16(4):443-9. PubMed ID: 1208828
    [No Abstract]   [Full Text] [Related]  

  • 40. Melanomas of the head and neck.
    Harwood AR
    J Otolaryngol; 1983 Feb; 12(1):64-9. PubMed ID: 6842653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.